{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:32:39Z","timestamp":1791689559158,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"shenzhen health commission (szhc): \u201ckey medical discipline construction fund\u201d","award":["No. SZXK077"],"award-info":[{"award-number":["No. SZXK077"]}]},{"DOI":"10.13039\/501100005847","name":"health and medical research fund","doi-asserted-by":"publisher","award":["No.07181676"],"award-info":[{"award-number":["No.07181676"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012234","name":"Shenzhen Peacock Plan","doi-asserted-by":"publisher","award":["20210830100C"],"award-info":[{"award-number":["20210830100C"]}],"id":[{"id":"10.13039\/501100012234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012234","name":"Shenzhen Peacock Plan","doi-asserted-by":"publisher","award":["20210802658C"],"award-info":[{"award-number":["20210802658C"]}],"id":[{"id":"10.13039\/501100012234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Osteogenesis imperfecta (OI) is a rare congenital disorder of the skeletal system, inflicting debilitating physical and psychological distress on patients and caregivers. Over the decades, much effort has been channeled towards understanding molecular mechanisms and developing new treatments. It has recently become more apparent that patient-reported outcome measurements (PROM) during treatment, healing and rehabilitation are helpful in facilitating smoother communication, refining intervention strategies and achieving higher quality of life. To date, systematic analyses of PROM in OI patients remain scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Here, utilizing a PROM Information System, we report a cross-sectional and longitudinal study in a southern Chinese cohort of 90 OI patients, covering both the child and adult age-groups. In the child group where both self and parental surveys were obtained, we identified two clusters of comparable sizes showing different outlooks in physical mobility and emotional experiences. One cluster (Cluster 1) is more negative about themselves than the other (Cluster 2). A concordance of 84.7% between self and parental assessments was recorded, suggesting the stability and validity of PROM-based stratification. Clinical subtyping, deformity, leg length discrepancy, and limited joint mobility were significantly associated with this stratification, with Cluster 1 showing higher percentages of severe phenotypes than Cluster 2. Since OI is a genetic disorder, we performed genetic testing on 72 of the 90 patients, but found no obvious association between genotypes and the PROM stratification. Analyses of longitudinal data suggested that patients tended to stay in the same psychological state, in both clusters. Adult patients also showed a continuous spectrum of self-evaluation that matches their clinical manifestations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By systematically analyzing patient-reported outcomes, our study demonstrated the link between the\u00a0sociopsychological wellbeing of OI patients, and their clinical manifestations, which may serve as the basis for evaluating clinical interventions and help achieve better patient-centric medical practices. The lack of genotype-PROM association may be due to the diverse mutational spectrum in OI, which warrants further investigation when a larger sample size is available.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-022-02394-7","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T07:05:38Z","timestamp":1656399938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient-reported outcomes in a Chinese cohort of osteogenesis imperfecta unveil psycho-physical stratifications associated with clinical manifestations"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-0893","authenticated-orcid":false,"given":"Peikai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-5169","authenticated-orcid":false,"given":"Zhijia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yapeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangsen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu Tung","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H. K.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-5199","authenticated-orcid":false,"given":"Bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-0419","authenticated-orcid":false,"given":"Kenneth Man Chee","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-0591","authenticated-orcid":false,"given":"Michael Kai-Tsun","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"2394_CR1","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, Bachinger HP, Bishop NJ, Byers PH, Paepe A, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2394_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ejhg.2015.81","volume":"23","author":"K Lindahl","year":"2015","unstructured":"Lindahl K, Astrom E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren O, et al. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet. 2015;23(8):1042\u201350.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"2394_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007;28(3):209\u201321.","journal-title":"Hum Mutat"},{"issue":"10028","key":"2394_CR4","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. 2016;387(10028):1657\u201371.","journal-title":"Lancet"},{"issue":"1","key":"2394_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40246-017-0115-5","volume":"11","author":"L Zhytnik","year":"2017","unstructured":"Zhytnik L, Maasalu K, Reimann E, Prans E, Koks S, Martson A. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Hum Genomics. 2017;11(1):19.","journal-title":"Hum Genomics"},{"issue":"4","key":"2394_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/bioinformatics\/bty682","volume":"35","author":"M Li","year":"2019","unstructured":"Li M, Jiang L, Mak TSH, Kwan JSH, Xue C, Chen P, et al. A powerful conditional gene-based association approach implicated functionally important genes for schizophrenia. Bioinformatics. 2019;35(4):628\u201335.","journal-title":"Bioinformatics"},{"issue":"4","key":"2394_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jmedgenet-2017-104999","volume":"55","author":"M Doyard","year":"2018","unstructured":"Doyard M, Bacrot S, Huber C, Di Rocco M, Goldenberg A, Aglan MS, et al. FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta. J Med Genet. 2018;55(4):278\u201384.","journal-title":"J Med Genet"},{"issue":"8","key":"2394_CR8","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/jbmr.4011","volume":"35","author":"J Dubail","year":"2020","unstructured":"Dubail J, Brunelle P, Baujat G, Huber C, Doyard M, Michot C, et al. Homozygous loss-of-function mutations in CCDC134 are responsible for a severe form of osteogenesis imperfecta. J Bone Miner Res. 2020;35(8):1470\u201380.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2394_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ajhg.2019.08.008","volume":"105","author":"S Moosa","year":"2019","unstructured":"Moosa S, Yamamoto GL, Garbes L, Keupp K, Beleza-Meireles A, Moreno CA, et al. Autosomal-recessive mutations in MESD Cause Osteogenesis Imperfecta. Am J Hum Genet. 2019;105(4):836\u201343.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2394_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164A","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164A(6):1470\u201381.","journal-title":"Am J Med Genet A"},{"issue":"5B","key":"2394_CR11","first-page":"113","volume":"15","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Rimoin DL, Danks DM. Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser. 1979;15(5B):113\u201329.","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"2","key":"2394_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101\u201316.","journal-title":"J Med Genet"},{"key":"2394_CR13","doi-asserted-by":"publisher","first-page":"540178","DOI":"10.4061\/2011\/540178","volume":"2011","author":"IM Ben Amor","year":"2011","unstructured":"Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011;2011:540178.","journal-title":"J Osteoporos"},{"key":"2394_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3389\/fphar.2019.01200","volume":"10","author":"J Shi","year":"2019","unstructured":"Shi J, Ren M, Jia J, Tang M, Guo Y, Ni X, et al. Genotype-phenotype association analysis reveals new pathogenic factors for osteogenesis imperfecta disease. Front Pharmacol. 2019;10:1200.","journal-title":"Front Pharmacol"},{"key":"2394_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/pan.14454","volume":"32","author":"X Liang","year":"2022","unstructured":"Liang X, Chen P, Chen C, Che W, Yang Y, Tan Z, et al. Comprehensive risk assessments and anesthetic management for children with osteogenesis imperfecta: A retrospective review of 252 orthopedic procedures over 5 years. Paediatr Anaesth. 2022;32:851.","journal-title":"Paediatr Anaesth."},{"issue":"5","key":"2394_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00223-017-0301-4","volume":"101","author":"JD Hald","year":"2017","unstructured":"Hald JD, Folkestad L, Harslof T, Brixen K, Langdahl B. Health-related quality of life in adults with osteogenesis imperfecta. Calcif Tissue Int. 2017;101(5):473\u20138.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"2394_CR17","doi-asserted-by":"publisher","first-page":"e10416","DOI":"10.1002\/jbm4.10416","volume":"4","author":"K Gooijer","year":"2020","unstructured":"Gooijer K, Harsevoort AGJ, van Dijk FS, Withaar HR, Janus GJM, Franken AAM. A Baseline measurement of quality of life in 322 adults with osteogenesis imperfecta. JBMR Plus. 2020;4(12):e10416.","journal-title":"JBMR Plus"},{"issue":"1","key":"2394_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13023-016-0538-4","volume":"11","author":"L Forestier-Zhang","year":"2016","unstructured":"Forestier-Zhang L, Watts L, Turner A, Teare H, Kaye J, Barrett J, et al. Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis. 2016;11(1):160.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2394_CR19","first-page":"99","volume":"21","author":"A Szczepaniak-Kubat","year":"2012","unstructured":"Szczepaniak-Kubat A, Kurnatowska O, Jakubowska-Pietkiewicz E, Chlebna-Sokol D. Assessment of quality of life of parents of children with osteogenesis imperfecta. Adv Clin Exp Med. 2012;21(1):99\u2013104.","journal-title":"Adv Clin Exp Med"},{"key":"2394_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12955-015-0226-4","volume":"13","author":"AP Vanz","year":"2015","unstructured":"Vanz AP, Felix TM, da Rocha NS, Schwartz IV. Quality of life in caregivers of children and adolescents with Osteogenesis Imperfecta. Health Qual Life Outcomes. 2015;13:41.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"2394_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.pedhc.2018.12.003","volume":"33","author":"MA Lazow","year":"2019","unstructured":"Lazow MA, Jaser SS, Cobry EC, Garganta MD, Simmons JH. Stress, depression, and quality of life among caregivers of children with osteogenesis imperfecta. J Pediatr Health Care. 2019;33(4):437\u201345.","journal-title":"J Pediatr Health Care"},{"issue":"1","key":"2394_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ajmg.a.37377","volume":"170A","author":"N Dahan-Oliel","year":"2016","unstructured":"Dahan-Oliel N, Oliel S, Tsimicalis A, Montpetit K, Rauch F, Dogba MJ. Quality of life in osteogenesis imperfecta: a mixed-methods systematic review. Am J Med Genet A. 2016;170A(1):62\u201376.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"2394_CR23","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010;63(11):1179\u201394.","journal-title":"J Clin Epidemiol"},{"key":"2394_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13023-015-0362-2","volume":"10","author":"LL Tosi","year":"2015","unstructured":"Tosi LL, Oetgen ME, Floor MK, Huber MB, Kennelly AM, McCarter RJ, et al. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis. 2015;10:146.","journal-title":"Orphanet J Rare Dis"},{"key":"2394_CR25","doi-asserted-by":"crossref","unstructured":"Tosi LL, Floor MK, Dollar CM, Gillies AP, Members of the Brittle Bone Disease C, Hart TS et al. Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study. Orphanet J Rare Dis. 2019;14(1):23.","DOI":"10.1186\/s13023-019-1004-x"},{"issue":"6","key":"2394_CR26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1359\/jbmr.091109","volume":"25","author":"F Rauch","year":"2010","unstructured":"Rauch F, Lalic L, Roughley P, Glorieux FH. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res. 2010;25(6):1367\u201374.","journal-title":"J Bone Miner Res"},{"key":"2394_CR27","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"1","key":"2394_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13023-021-01682-y","volume":"16","author":"W Nijhuis","year":"2021","unstructured":"Nijhuis W, Franken A, Ayers K, Damas C, Folkestad L, Forlino A, et al. A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta. Orphanet J Rare Dis. 2021;16(1):140.","journal-title":"Orphanet J Rare Dis"},{"issue":"20","key":"2394_CR29","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/bioinformatics\/btu356","volume":"30","author":"H Li","year":"2014","unstructured":"Li H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinformatics. 2014;30(20):2843\u201351.","journal-title":"Bioinformatics"},{"issue":"9","key":"2394_CR30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"2","key":"2394_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80\u201392.","journal-title":"Fly (Austin)"},{"issue":"16","key":"2394_CR32","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2394_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/00401706.1972.10488966","volume":"14","author":"WA Larsen","year":"1972","unstructured":"Larsen WA, McCleary SJ. The use of partial residual plots in regression analysis. Technometrics. 1972;14(3):781\u201390.","journal-title":"Technometrics"},{"key":"2394_CR34","volume-title":"Handbook of biostatistics : a review and text","author":"CP Carvounis","year":"2000","unstructured":"Carvounis CP. Handbook of biostatistics\u202f: a review and text. New York: Parthenon Publishing; 2000."},{"key":"2394_CR35","doi-asserted-by":"publisher","first-page":"816078","DOI":"10.3389\/fgene.2022.816078","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Tan Z, Shek HT, Zhang JN, Zhou Y, Yin S, et al. Phenotypic spectrum and molecular basis in a chinese cohort of osteogenesis imperfecta with mutations in type i collagen. Front Genet. 2022;13:816078.","journal-title":"Front Genet"},{"issue":"1","key":"2394_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/ahg.12403","volume":"85","author":"V Madhuri","year":"2021","unstructured":"Madhuri V, Selina A, Loganathan L, Kumar A, Kumar V, Raymond R, et al. Osteogenesis imperfecta: Novel genetic variants and clinical observations from a clinical exome study of 54 Indian patients. Ann Hum Genet. 2021;85(1):37\u201346.","journal-title":"Ann Hum Genet"},{"key":"2394_CR37","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3389\/fgene.2020.00984","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, Cao Y, Wang H, Li L, Ren X, Mi H, et al. Genotypic and phenotypic analysis in chinese cohort with autosomal recessive osteogenesis imperfecta. Front Genet. 2020;11:984.","journal-title":"Front Genet"},{"issue":"10","key":"2394_CR38","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s00198-017-4143-8","volume":"28","author":"Y Liu","year":"2017","unstructured":"Liu Y, Asan MD, Lv F, Xu X, Wang J, et al. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int. 2017;28(10):2985\u201395.","journal-title":"Osteoporos Int."},{"issue":"8","key":"2394_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0003-9993(99)90080-1","volume":"80","author":"RH Engelbert","year":"1999","unstructured":"Engelbert RH, Beemer FA, van der Graaf Y, Helders PJ. Osteogenesis imperfecta in childhood: impairment and disability\u2014a follow-up study. Arch Phys Med Rehabil. 1999;80(8):896\u2013903.","journal-title":"Arch Phys Med Rehabil"},{"key":"2394_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2431-13-153","volume":"13","author":"MJ Dogba","year":"2013","unstructured":"Dogba MJ, Bedos C, Durigova M, Montpetit K, Wong T, Glorieux FH, et al. The impact of severe osteogenesis imperfecta on the lives of young patients and their parents\u2014a qualitative analysis. BMC Pediatr. 2013;13:153.","journal-title":"BMC Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02394-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T20:49:44Z","timestamp":1700772584000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02394-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2394"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02394-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"17 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) approvals (ETHICS-2019-010; ETHICS-2020-190; ETHICS-2021-141) were obtained from the Medical Ethical Committee of the University of Hong Kong-Shenzhen Hospital. Informed consents were obtained from the patients or their parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}